Teva Announces Launch of Generic Xeloda Tablets 150 MG and 500 MG in the United States

10-03-2014 Business Wire HealthComments (0)

GenericsTeva Pharmaceutical IndustriesUSAXeloda

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces the launch of the generic equivalent to Xeloda (Capecitabine) Tablets, 150 MG and 500 MG, in the United States. Xeloda is marketed by Genentech in the United States. Teva was the first to receive approval on its ANDA from the U.S. Food and Drug Administration on September 16, 2013 and is launching today per a settlement agreement. Xeloda (Capecitabine) Tablets, 150 MG and 500 MG had annual sales of approxi

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top